Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Novel translocation of POGZ/STK11 in de novo mast cell leukemia with KIT D816H mutation.
Ishitsuka K, Yoshizawa Y, Nishikii H, Kusakabe M, Ito Y, Inadome Y, Sakamoto T, Kato T, Kurita N, Yokoyama Y, Obara N, Hasegawa Y, Nannya Y, Ogawa S, Sakata-Yanagimoto M, Chiba S. Ishitsuka K, et al. Leuk Lymphoma. 2022 Dec;63(14):3475-3479. doi: 10.1080/10428194.2022.2123235. Epub 2022 Sep 20. Leuk Lymphoma. 2022. PMID: 36126964 No abstract available.
High efficacy of eculizumab treatment for fulminant hemolytic anemia in primary cold agglutinin disease.
Makishima K, Obara N, Ishitsuka K, Sukegawa S, Suma S, Kiyoki Y, Baba N, Sakamoto T, Kato T, Kusakabe M, Nishikii H, Kurita N, Yokoyama Y, Sakata-Yanagimoto M, Hasegawa Y, Chiba S. Makishima K, et al. Among authors: ishitsuka k. Ann Hematol. 2019 Apr;98(4):1031-1032. doi: 10.1007/s00277-018-3521-4. Epub 2018 Oct 15. Ann Hematol. 2019. PMID: 30324459 No abstract available.
Dasatinib Is an Effective Treatment for Angioimmunoblastic T-cell Lymphoma.
Nguyen TB, Sakata-Yanagimoto M, Fujisawa M, Nuhat ST, Miyoshi H, Nannya Y, Hashimoto K, Fukumoto K, Bernard OA, Kiyoki Y, Ishitsuka K, Momose H, Sukegawa S, Shinagawa A, Suyama T, Sato Y, Nishikii H, Obara N, Kusakabe M, Yanagimoto S, Ogawa S, Ohshima K, Chiba S. Nguyen TB, et al. Among authors: ishitsuka k. Cancer Res. 2020 May 1;80(9):1875-1884. doi: 10.1158/0008-5472.CAN-19-2787. Epub 2020 Feb 27. Cancer Res. 2020. PMID: 32107212 Clinical Trial.
Administration of brentuximab vedotin to a Hodgkin lymphoma patient with liver dysfunction due to vanishing bile duct syndrome resulting in a partial response without any severe adverse events.
Ishitsuka K, Yokoyama Y, Baba N, Matsuoka R, Sakamoto N, Sakamoto T, Kusakabe M, Kato T, Kurita N, Nishikii H, Sakata-Yanagimoto M, Obara N, Hasegawa Y, Chiba S. Ishitsuka K, et al. J Clin Exp Hematop. 2022 Sep 28;62(3):154-157. doi: 10.3960/jslrt.21035. Epub 2022 Jul 12. J Clin Exp Hematop. 2022. PMID: 35831099 Free PMC article.
Chemically defined cytokine-free expansion of human haematopoietic stem cells.
Sakurai M, Ishitsuka K, Ito R, Wilkinson AC, Kimura T, Mizutani E, Nishikii H, Sudo K, Becker HJ, Takemoto H, Sano T, Kataoka K, Takahashi S, Nakamura Y, Kent DG, Iwama A, Chiba S, Okamoto S, Nakauchi H, Yamazaki S. Sakurai M, et al. Among authors: ishitsuka k. Nature. 2023 Mar;615(7950):127-133. doi: 10.1038/s41586-023-05739-9. Epub 2023 Feb 22. Nature. 2023. PMID: 36813966 Free article.
Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard-dose azacitidine.
Ogawa S, Sakamoto T, Matsuoka R, Ishitsuka K, Ogino Y, Sootome A, Makishima K, Yoshida C, Ito Y, Shimizu S, Suyama T, Shinagawa A, Ito T, Obara N, Kusakabe M, Sakata-Yanagimoto M, Miyazaki Y, Nannya Y, Chiba S. Ogawa S, et al. Among authors: ishitsuka k. Cancer Rep (Hoboken). 2024 Jan;7(1):e1938. doi: 10.1002/cnr2.1938. Epub 2023 Nov 28. Cancer Rep (Hoboken). 2024. PMID: 38014499 Free PMC article.
237 results